$5,499.00
In Stock
Zykadia is an antineoplastic and immunomodulatory agent; protein kinase inhibitor.
Indications:
– locally advanced or metastatic non-small cell lung cancer (NSCLC), positive for anaplastic lymphoma kinase (ALK) in adult patients;
– locally advanced or metastatic non-small cell lung cancer (NSCLC), positive for anaplastic lymphoma kinase (ALK) in adult patients previously treated with crizotinib.
Active ingredient: ceritinib
Shipped from Germany
Prescription medicine
